a nonsignificant trendp = 0.12
Patients with detectable KRAS ctDNA but preserved PNI (≥ 45) also demonstrated a nonsignificant trend toward worse survival (HR 2.22, 95% CI 0.82–5.99, p = 0.12).
Patients with detectable KRAS ctDNA but preserved PNI (≥ 45) also demonstrated a nonsignificant trend toward worse survival (HR 2.22, 95% CI 0.82–5.99, p = 0.12).